Ethnicity delineates different genetic pathways in malignant glioma

Cancer Research

Volumn 61, Issue 10, 2001, Pages 3949-3954

  Chen, Pengchin ^a   Aldape, Kenneth ^b   Wiencke, John K ^a   Kelsey, Karl T ^c   Miike, Rei ^a   Davis, Richard L ^b   Liu, Jennifer ^a   Kesler Diaz, Anna ^a   Takahashi, Michelle ^b   Wrensch, Margaret ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; ETHNIC DIFFERENCE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; ETHNIC GROUPS; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035872444     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Environmental risk factors for primary malignant brain tumors: A review
2. Etiology of brain tumors in adults
3. Cancer incidence by race/ethnicity in the San Francisco Bay area
4. Genetics of primary brain tumors: A review
5. A molecular genetic model of astrocytoma histopathology
6. Molecular biology of central nervous system tumors
7. Molecular biology of malignant degeneration of astrocytoma
8. Phenotype vs. genotype in the evolution of astrocytic brain tumors
9. p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment
10. ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities
11. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification
12. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer
13. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells
14. Accumulation of wild type p53 protein in human astrocytomas
15. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
16. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
17. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
18. The p53 gene and protein in human brain tumors
19. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
20. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls
21. Cytoplasmically. "sequestered" wild type p53 protein is resistant to Mdm2-mediated degradation
22. Spontaneous occurrence and chemical induction of neurogenic tumors in rats - Influence of host factors and specificity of chemical structure
23. The molecular epidemiology of p53 gene mutations in human breast cancer
24. Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients
25. Comparative study of p53 gene and protein alterations in human astrocytic tumors
26. Molecular genetic alterations in radiation-induced astrocytomas
27. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties